Last update 02 May 2024

Servier (Tianjin) Pharmaceutical Co Ltd

Private Company|
2000|
Tianjin Shi, China
|

Overview

Basic Info

Introduction
Servier (Tianjin) Pharmaceutical Co Ltd is one of the sixteen production bases that Servier Group has set up globally. It is the only production base in Asia that supplies original research drugs to China and certain Asian countries, while also supporting local clinical research. Servier (Tianjin) Pharmaceutical Co Ltd has rich experience in the consistency evaluation of generic drugs and the development of innovative drugs. Not only does it localize the production of original research drugs of Servier, meeting the needs of a large number of Chinese patients in cardiovascular metabolism, venous health, and tumor fields, but it also provides long-term drug processing services for other Asian countries such as South Korea. Servier (Tianjin) Pharmaceutical Co Ltd possesses a sound and mature quality management system and industry-leading introduced equipment. It is committed to continuously optimizing environmental protection measures and improving production efficiency, professional service quality, and management efficiency. Furthermore, the Tianjin Production Base offers pharmaceutical production outsourcing (CMO) services, aiding clients in rapidly promoting project implementation.

Tags

Cardiovascular Diseases
Respiratory Diseases
Digestive System Disorders
Small molecule drug
Herbal medicine

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Top 5 Drug TypeCount
Small molecule drug4
Herbal medicine1

Corporation Tree

Boost your research with our corporation tree data.
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 02 Jul 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
NDA/BLA
1
4
Approved
Other
1
Login to view more data

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
Unearth financing trends to validate and advance investment opportunities.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free